Potential Therapies

These ‘articles in a nutshell’ provide a balanced, straightforward and realistic overview of new science in Parkinson’s, and what it really means in the context of moving towards a cure.

Understanding the Nilotinib trials

Understanding the Nilotinib trials

The results of a Phase II trial on the safety of nilotinib in people with Parkinson’s has shown ambiguous biochemical results and a greater number of adverse events in the treated groups.

read more

Pin It on Pinterest

Share This